alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2013274EN.01000203.xml

| 21.9.2013 | EN | Official Journal of the European Union | C 274/2 |
| --- | --- | --- | --- |

21.9.2013

EN

Official Journal of the European Union

C 274/2

---

Request for a preliminary ruling from the Unabhängiger Verwaltungssenat Wien (Austria) lodged on 17 June 2013 — Ferdinand Stefan

(Case C-329/13)

2013/C 274/04

Language of the case: German

Referring court

Referring court

Unabhängiger Verwaltungssenat Wien

Parties to the main proceedings

Parties to the main proceedings

Applicant: Ferdinand Stefan

Applicant:

Defendant: Federal Minister for Agriculture, Forestry, the Environment and Water Management

Defendant:

Questions referred

Questions referred

| 1. | As regards the validity of Environmental Information Directive 2003/4/EC: (1)

  Pursuant to subparagraph (b) of the first sentence of Article 267 TFEU, is Directive 2003/4/EC valid in its entirety and/or are all parts of Directive 2003/4/EC valid, in particular having regard to the requirements of the second paragraph of Article 47 of the Charter of Fundamental Rights of the European Union? |
| --- | --- |

1.

As regards the validity of Environmental Information Directive 2003/4/EC: (1)

1

Pursuant to subparagraph (b) of the first sentence of Article 267 TFEU, is Directive 2003/4/EC valid in its entirety and/or are all parts of Directive 2003/4/EC valid, in particular having regard to the requirements of the second paragraph of Article 47 of the Charter of Fundamental Rights of the European Union?

| 2. | As regards the interpretation of Environmental Information Directive 2003/4/EC:
  In the event that the Court of Justice of the European Union affirms the validity of Directive 2003/4/EC in its entirety or the validity of parts of Directive 2003/4/EC, the Court of Justice is requested, pursuant to subparagraphs (a) and (b) of the first sentence of Article 267 TFEU, to give a ruling on the extent to which, and the assumptions on the basis of which, the provisions of the Environmental Information Directive are compatible with the provisions of the Charter of Fundamental Rights of the European Union and the requirements of Article 6 TEU. |
| --- | --- |

2.

As regards the interpretation of Environmental Information Directive 2003/4/EC:

In the event that the Court of Justice of the European Union affirms the validity of Directive 2003/4/EC in its entirety or the validity of parts of Directive 2003/4/EC, the Court of Justice is requested, pursuant to subparagraphs (a) and (b) of the first sentence of Article 267 TFEU, to give a ruling on the extent to which, and the assumptions on the basis of which, the provisions of the Environmental Information Directive are compatible with the provisions of the Charter of Fundamental Rights of the European Union and the requirements of Article 6 TEU.

---

(1)  Directive 2003/4/EC of the European Parliament and of the Council of 28 January 2003 on public access to environmental information and repealing Council Directive 90/313/EEC (OJ 2003 L 41, p. 26).

1

---
[Federal Register Volume 63, Number 119 (Monday, June 22, 1998)]
[Notices]
[Page 33964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16528]


-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Special Emphasis Panel in Bioengineering and Environmental 
Systems; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting.

    Name: Special Emphasis Panel in Bioengineering and Environmental 
Systems (1189).
    Date and Time: July 22-23, 1998; 8:30 a.m.-5:00 p.m.
    Place: National Science Foundation, 4201 Wilson Boulevard, Room 
580, Arlington, VA 22230.
    Type of Meeting: Closed.
    Contact Person: Fred G. Heineken, Program Director, 
Biotechnology Engineering, Division of Bioengineering and 
Environmental Systems, National Science Foundation, 4201 Wilson 
Boulevard, Arlington, VA 22230, Telephone: (703) 306-1318.
    Purpose of Meeting: To provide advice and recommendations 
concerning proposals submitted to NSF for financial support.
    Agenda: To review and evaluate the 1998 Inter-Agency Metabolic 
Engineering proposals as part of the selection process for awards.
    Reason for Closing: The proposals being reviewed include 
information of a proprietary or confidential nature, including 
technical information; financial data, such as salaries; and 
personal information concerning individuals associated with the 
proposals. These matters are exempt under 5 U.S.C. 552b(c) (4) and 
(6) of the Government in the Sunshine Act.

    Dated: June 16, 1998.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 98-16528 Filed 6-19-98; 8:45 am]
BILLING CODE 7555-01-M
#### Nakajima v. Nakajima

29553

05/09/2014

Affirmed
#### Com. v. Wheeler

12/16/2015

316 WAL (2015)

Denied

Pa.Super., 125 A.3d 442
No. 10-5942.

#### Honorio Moreno Herrera, Petitioner v. California.

562 U.S. 942, 131 S. Ct. 361,

178 L. Ed. 2d 233,

2010 U.S. LEXIS 7245.

October 4, 2010.

Petition for writ of certiorari to the Supreme Court of California denied.

Same case below, 49 Cal. 4th 613, 110 Cal. Rptr. 3d 729, 232 P.3d 710.
#### In the Matter of Sharice B., a Person Alleged to be a Juvenile Delinquent, Appellant.

[51 NYS3d 620]

Appeal from an order of disposition of the Family Court, Richmond County (Peter F. DeLizzo, J.), dated July 19, 2016. The order of disposition adjudicated Sharice B. a juvenile delinquent and placed him under the care and custody of the New York State Office of Children and Family Services for a period not to exceed 18 months, but no less than 6 months, with a credit of 1 month for time served in detention pending disposition. The appeal brings up for review so much of an order of fact-finding of that court dated May 25, 2016, made upon Sharice B.’s admission, as found that he committed acts which, if committed by an adult, would have constituted the crime of robbery in the first degree.

Ordered that the order of disposition is modified, on the law, by vacating the provision thereof crediting the appellant with 1 month for time served in detention pending disposition, and substituting therefor a provision crediting the appellant with 2 months for time served in detention pending disposition; as so modified, the order of disposition is affirmed, without costs or disbursements.

Contrary to the appellant’s contention, the Family Court did not improvidently exercise its discretion in denying his request for a lesser restrictive placement. The Family Court has broad discretion in determining dispositions *(see*Family Ct Act § 141; *Matter of Naiquan T.,*265 AD2d 331 [1999]; *Matter of Tristan*W., 258 AD2d 585 [1999]). “ ‘[T]he least restrictive alternative test does not require the court to actually try the lowest form of intervention, have it fail, and then try each succeeding level of intervention before ordering . . . placement’ ” *(Matter of Tristan W.,*258 AD2d at 586, quoting *Matter of Anthony M.,*142 AD2d 731, 732 [1988]; see *Matter of Jamil*W., 184 AD2d 513, 514 [1992]). Here, the court’s determination demonstrated that it carefully considered the less-restrictive alternatives to the appellant’s placement, and properly balanced the needs of the appellant and the need for the protection of the community *(see*Family Ct Act § 352.2 [2]).

Contrary to the appellant’s contention, the record demon*834strates that he was advised of all possible dispositional alternatives and was properly allocuted *(see*Family Ct Act § 321.3 [1]).

The appellant served 2 months in predisposition detention, but the Family Court credited him with only 1 month. As such, the court was required to make a specific finding that crediting the appellant with the entire period of predisposition detention would not serve the interests of the appellant or the community (see Family Ct Act § 353.3 [5]; *Matter of Miranda C.,*103 AD3d 891, 894 [2013]). However, it failed to do so. Accordingly, the appellant is entitled to credit for all predisposition detention as a result of the charge that culminated in the period of placement (see *Matter of Miranda C.,*103 AD3d at 894).

The appellant’s remaining contention is without merit.

Dillon, J.P., Austin, Hinds-Radix and Maltese, JJ., concur.
[Federal Register Volume 63, Number 119 (Monday, June 22, 1998)]
[Notices]
[Page 33964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16523]


-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Advisory Committee for Biological Sciences; Committee of 
Visitors, Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting:

    Name: Advisory Committee for Biological Sciences: Committee of 
Visitors (1110).
    Date and Time: July 22-24, 1998; 8:30 A.M. to 5:00 P.M. each 
day.
    Place: National Science Foundation, Room 330, 4201 Wilson 
Boulevard, Arlington, Virginia 22230.
    Contact Person: Dr. Maryanna Henkart, Division Director for 
Molecular and Cellular Biosciences, National Science Foundation, 
4201 Wilson Boulevard, Arlington, Virginia, (703) 306-1440.
    Purpose of Meeting: To carry out Committee of Visitors (COV) 
review, including program evaluation, GPRA assessments, and access 
to privileged materials.
    Type of Meeting: Part open (see agenda below):

Agenda

    Closed: July 22 (11:00 a.m.-5:00 p.m.); July 23 (8:30 a.m.-9:00 
a.m., and 2:00 p.m.-5:00 p.m.); and July 24 (8:30 a.m.-12:00 a.m.)--
To review the merit review processes covering funding decisions made 
during the immediately preceding three fiscal years of programs in 
the Division of Molecular and Cellular Biosciences.
    Open: July 22 (8:30 a.m.-11:00 a.m.); July 23 (9:00 a.m.-2:00 
p.m.), and July 24 (1:00 p.m.-4:00 p.m.)--To assess the results of 
NSF program investments in the Molecular and Cellular Biosciences 
Division. This shall involve a discussion and review of results 
focused on NSF and grantee outputs and related outcomes achieved or 
realized during the preceding three fiscal years. These results may 
be based on NSF grants or other investments made in earlier years.
    Reason for Closing: During the closed session, the Committee 
will be reviewing proposal actions that will include privileged 
intellectual property and personal information that could harm 
individuals if they were disclosed. If discussions were open to the 
public, these matters that are exempt under 5 U.S.C. 552b(c) (4) and 
(6) of the Government in the Sunshine Act would be improperly 
disclosed.

    Dated: June 17, 1998.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 98-16523 Filed 6-19-98; 8:45 am]
BILLING CODE 7555-01-M
<PAGE>

                                                                    EXHIBIT 10.3

                               THIRD AMENDMENT TO
                                   ALLOY, INC.
                              AMENDED AND RESTATED
                     1997 EMPLOYEE, DIRECTOR AND CONSULTANT
                      STOCK OPTION AND STOCK INCENTIVE PLAN

      THIS THIRD AMENDMENT (the "THIRD AMENDMENT") to the Alloy, Inc. Amended
and Restated 1997 Employee, Director and Consultant Stock Option and Stock
Incentive Plan, as amended by the First Amendment thereto dated May 28, 2003 and
the Second Amendment thereto dated as of July 25, 2003 (as so amended, the
"PLAN"), is made as of June __, 2004. Capitalized terms used herein, and not
otherwise defined herein, shall have the respective meanings ascribed to them in
the Plan.

      WHEREAS, the Board of Directors (the "BOARD") of Alloy, Inc. (the
"COMPANY") previously adopted, and currently maintains, the Plan; and

      WHEREAS, the Board has deemed it desirable to further amend the Plan to
eliminate the Company's obligations with respect to the mandatory issuance of
Non-Qualified Options under the Plan to non-employee members of the Board; and

      WHEREAS, pursuant to Section 33 of the Plan, the Board, as the
Administrator, has the power to amend the Plan to effect such amendment, and the
Board has adopted resolutions providing for such amendment.

      NOW, THEREFORE, the Plan is hereby amended as follows:

      1. Section 6(A)(e) of the Plan is hereby deleted in its entirety.

      Except as expressly set forth herein, the Plan remains in full force and
effect.
[Federal Register Volume 63, Number 105 (Tuesday, June 2, 1998)]
[Notices]
[Pages 29979-29980]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-14559]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability of U.S. Patents for Non-Exclusive, Exclusive, or 
Partially Exclusive Licensing

AGENCY: U.S. Army Research Laboratory, Adelphi, Maryland.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability of the following U.S. patents for non-exclusive, partially 
exclusive or exclusive licensing. All of the listed patents have been 
assigned to the United States of America as represented by the 
Secretary of the Army, Washington, D.C.
    These patents cover a wide variety of technical arts including: A 
method for ultrasensitive detection of atmospheric Nitrocompounds using 
excimer laser radiation and a method for determining ocular gaze point 
of regard and fixation duration.
    Under the authority of Section 11(a)(2) of the Federal Technology 
Transfer Act of 1986 (Public Law 99-502) and Section 207 of title 35, 
United States Code, the Department of the Army as represented by the 
U.S. Army Research Laboratory wish to license the U.S. patents listed 
below in a non-exclusive, exclusive or partially exclusive manner to 
any party interested in manufacturing, using, and/or selling devices or 
processes covered by these patients.
    Title: Method and Apparatus for Determining Ocular Gaze Point of 
Regard and Fixation Duration.

[[Page 29980]]

    Inventor: Christopher C. Smyth.
    Patent Number: 5,726,916.
    Issued Date: March 10, 1998.
    Title: Method for Detecting Nitrocompounds Using Excimer Laser 
Radiation.
    Inventor: Rosario C. Sausa.
    Patent Number: 5,728,584.
    Issued Date: March 17, 1998.

FOR FURTHER INFORMATION CONTACT:
Mr. Mike Rausa, Technology Transfer Office, AMSRL-CS-TT, U.S. Army 
Research Laboratory, Aberdeen Proving Ground, Maryland 21005-5055, tel: 
(401) 278-5028; fax: (410) 278-5820.

SUPPLEMENTARY INFORMATION: None.
Mary V. Yonts,
Alternate Army Federal Register Liaison Officer.
[FR Doc. 98-14559 Filed 6-1-98; 8:45 am]
BILLING CODE 3710-08-M
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[S. 2508 Introduced in Senate (IS)]

103d CONGRESS
  2d Session
                                 S. 2508

To amend the fishing endorsement issued to a vessel owned by Ronnie C. 
                            Fisheries, Inc.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

            October 5 (legislative day, September 12), 1994

 Mr. Packwood introduced the following bill; which was read twice and 
   referred to the Committee on Commerce, Science, and Transportation

_______________________________________________________________________

                                 A BILL

 
To amend the fishing endorsement issued to a vessel owned by Ronnie C. 
                            Fisheries, Inc.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FISHING ENDORSEMENT.

    Notwithstanding any other provision of law, the size endorsement on 
Pacific Coast Groundfish Limited Entry Permit Number GF0351, issued to 
Ronnie C. Fisheries Incorporated, is hereby amended to read ``150 
feet'' length overall.
                                 <all>
```
### MEMORANDUM

To: Debbie Ottinger

, U.S. EPA

From: MarianVan Pelt

, Toby Krasney

, ICF International

Date: May 20, 2008

Re: ICF Research on U.S Other Anesthetics Industry

Per your request, this memo summarizes ICF’s research on the anesthetics Sevoflurane, Isoflurane, and Desflurane. In summary, there are six pr imary producers in the United States. In addition, six additional companies were identified as suppl iers or distributors. Production or capacity levels by corporation, and sales documents by gas were not found in our research.

The table below summarizes the companies identified withi n the supply chain.

Company Gas Descriptor Abbott Laboratories Sevoflurane (28523-86-6) Produ cer AirGas Sevoflurane (28523-86-6) Producer/Distributor Isoflurane (26675-46-7) Producer/Distributor Desflurane (57041-67-5) Producer/Distributor Baxter Healthcare Corporation Sevoflurane (28523-86-6 ) Producer Isoflurane (26675-46-7) Producer Desflurane (57041-67-5) Producer Halocarbon Corporation Isoflurane (26675-46-7) Prod ucer MINRAD Incorporated Sevoflurane (28523-86-6) Produce r/Distributor Isoflurane (26675-46-7) Producer/Distributor Rhodia Inc., Perfumery Performance & Agro Isoflurane ( 26675-46-7) Producer Aceto Corporation Isoflurane (26675-46-7) Distributo r AK Scientific, Inc. Sevoflurane (28523-86-6) Distri butor Isoflurane (26675-46-7) Distributor LGM Pharmaceuticals Inc Sevoflurane (28523-86-6) Dist ributor Matrix Scientific Sevoflurane (28523-86-6) Supplier Isoflurane (26675-46-7) Supplier Desflurane (57041-67-5) Supplier Minneapolis Oxygen Company Sevoflurane (28523-86-6) Supplier Isoflurane (26675-46-7) Supplier Desflurane (57041-67-5) Supplier Xenos BioResources Sevoflurane (28523-86-6) Supplier Isoflurane (26675-46-7) Supplier

Two of the companies identified in the above table also pro duce an additional fluorinated anesthetic: MINRAD incorporated produces Enflurane, which is an isomer of isoflurane, and Rhodia, Inc. produces Halothane which has a bromine atom.

Please feel free to contact Toby Krasney ( tkrasney@icfi.com ) or Marian Van Pelt ( mvanpelt@icfi.com

) with comments or questions.
[Federal Register Volume 63, Number 120 (Tuesday, June 23, 1998)]
[Notices]
[Page 34187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16604]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Notice of Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Office of the Secretary, DHHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Advisory Committee on Blood Safety and Availability will meet 
on August 27, 1998, from 8:00 am to 5:00 pm and on August 28, 1998 from 
8:00 am to 3:00 pm. The meeting will take place in the Ticonderoga Room 
of the Hyatt Regency Hotel on Capitol Hill, 400 New Jersey, NW., 
Washington, DC. 2001. The meeting will be entirely open to the public.
    The Committee will consider potential barriers to the evolution 
from human- to recombinant-based blood products. On August 27, 1998 the 
committee will review information presented to it by representatives of 
consumers, industry and government agencies. At the conclusion of these 
presentations, the public will be invited to comment. Following these 
presentations, the Committee will consider what, if any, 
recommendations to make to the Department on this matter.
    Prospective speakers should notify the Executive Secretary of their 
desire to address the Committee and should plan for no more than 5 
minutes of comment.
    An attempt will be made to schedule future meetings of the Advisory 
Committee on Blood Safety and Availability on the last Thursday and 
Friday of January, April and August in 1999.

FOR FURTHER INFORMATION CONTACT:
Stephen D. Nightingale, M.D., Executive Secretary, Advisory Committee 
on Blood Safety and Availability, Office of Public Health and Safety, 
Department of Health and Human Services, 200 Independence Avenue, SW., 
Washington, DC 20201. Phone (202) 690-5560 FAX (202) 690-6584 e-mail 
<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="90c3ded9d7d8c4d9ded0ffe3ffe0f8e3bef4f8f8e3bef7ffe6be">[email protected]</a>

    Dated: June 15, 1998.
Stephen D. Nightingale, MD.,
Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
[FR Doc. 98-16604 Filed 6-22-98; 8:45 am]
BILLING CODE 4160-17-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# The DLA Rap talk show to highlight agency 'heroes,’ unique missions

/ Published Nov. 17, 2020
FORT BELVOIR, Va., 
Defense Logistics Agency employees and unique missions are the subject of a video talk show called The DLA Rap.“DLA people come from all walks of life and work so hard to support many different types of work. This series is about everyday DLA heroes, those on the frontlines and those who support from the back, because it’s all crucial to accomplishing the mission,” said Video Producer Nutan Chada, who has captured and shared footage of DLA for over 25 years.The first episode introduces Joe Sousa, chief of the Bulk Division at DLA Distribution San Joaquin, California, who has helped provide critical supplies to wildland firefighters during one of the most active fire seasons in U.S. history. New episodes are expected to appear monthly on Facebook, YouTube and the Defense Visual Information Distribution Service.“The beauty of The DLA Rap is that it’s a bit free-flowing and doesn’t have a set schedule, so we can highlight employees when the moment is right,” she said.Chada is already finalizing the second and third episodes, which will feature Jade Spurgeon, DLA’s occupational health manager, and DLA Senior Enlisted Leader Army Command Sgt. Maj. Tomeka O’Neal.Each episode takes a team of professionals who conduct shooting, lighting and audio whether interviews take place at DLA Headquarters, virtually or in the field.“It can take over two hours to shoot one segment, and then of course it can take more than a week to edit for prime time,” Chada said.She has traveled to places like Djibouti, Hawaii, Italy and Kuwait to spotlight the ways employees support customers around the world. Being an extrovert and travel restrictions during the COVID-19 pandemic inspired her to find new, creative ways to share DLA’s story.Viewers can recommend people and programs for future episodes or send feedback and suggestions to Nutan.Chada@dla.mil.04:23VIDEO  | 04:23 |DLA Rap, Meet Fire Support Hero, Joe Sousa
No. 10-5207.

#### Talib Watson, Petitioner v. United States.

562 U.S. 953, 131 S. Ct. 258,

178 L. Ed. 2d 251,

2010 U.S. LEXIS 7698.

October 4, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.

The Chief Justice took no part in the consideration or decision of this petition.

Same case below, 358 Fed. Appx. 207.
No. 10-6335.

#### Jason W. Black, Petitioner v. United States.

562 U.S. 974, 131 S. Ct. 491,

178 L. Ed. 2d 311,

2010 U.S. LEXIS 7897.

October 12, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
#### People v Arroyo

App Div, 1st Dept: 2016 NY Slip Op 71756(U) (NY)

denied 8/31/16 (DiFiore, Ch. J.)